Semi-Annual Balance Sheet

Oncolys BioPharma Inc. - Filing #7733573

Concept As at
2017-09-30
As at
2016-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,176,975,000 JPY
2,564,045,000 JPY
Other
65,000 JPY
34,000 JPY
Current assets
3,323,171,000 JPY
2,746,518,000 JPY
Accounts receivable - other
6,085,000 JPY
3,436,000 JPY
Prepaid expenses
26,353,000 JPY
17,474,000 JPY
Non-current assets
Property, plant and equipment
Buildings
2,794,000 JPY
2,794,000 JPY
Accumulated depreciation
-2,794,000 JPY
-2,794,000 JPY
Buildings, net
JPY
JPY
Property, plant and equipment
2,448,000 JPY
JPY
Tools, furniture and fixtures
66,787,000 JPY
66,630,000 JPY
Accumulated depreciation
-64,338,000 JPY
-66,630,000 JPY
Tools, furniture and fixtures, net
2,448,000 JPY
JPY
Investments and other assets
Investment securities
397,889,000 JPY
351,940,000 JPY
Shares of subsidiaries and associates
10,173,000 JPY
10,173,000 JPY
Investments and other assets
450,015,000 JPY
393,795,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term loans receivable from subsidiaries and associates
11,079,000 JPY
JPY
Long-term prepaid expenses
1,313,000 JPY
1,582,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
452,463,000 JPY
393,795,000 JPY
Assets
3,775,634,000 JPY
3,140,313,000 JPY
Liabilities
Current liabilities
Short-term borrowings
93,336,000 JPY
63,202,000 JPY
Lease liabilities
10,539,000 JPY
9,949,000 JPY
Income taxes payable
20,451,000 JPY
24,634,000 JPY
Current liabilities
245,068,000 JPY
204,849,000 JPY
Advances received
JPY
388,000 JPY
Accounts payable - other
104,072,000 JPY
89,739,000 JPY
Non-current liabilities
Non-current liabilities
365,231,000 JPY
318,080,000 JPY
Long-term borrowings
352,774,000 JPY
300,000,000 JPY
Lease liabilities
9,091,000 JPY
15,297,000 JPY
Liabilities
610,300,000 JPY
522,929,000 JPY
Other liabilities
Provision for retirement benefits
3,366,000 JPY
2,783,000 JPY
Other liabilities
Net assets
Share capital
5,764,213,000 JPY
5,090,981,000 JPY
Shareholders' equity
Deposits for subscriptions of shares
40,000 JPY
JPY
Capital surplus
Legal capital surplus
5,756,713,000 JPY
5,083,481,000 JPY
Capital surplus
5,756,713,000 JPY
5,083,481,000 JPY
Retained earnings
Other retained earnings
Retained earnings brought forward
-8,348,674,000 JPY
-7,569,313,000 JPY
Other retained earnings
Retained earnings
-8,348,674,000 JPY
-7,569,313,000 JPY
Shareholders' equity
3,172,291,000 JPY
2,605,149,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-18,091,000 JPY
-8,370,000 JPY
Valuation and translation adjustments
-18,091,000 JPY
-8,370,000 JPY
Net assets
3,165,334,000 JPY
2,617,383,000 JPY
Share acquisition rights
11,133,000 JPY
20,604,000 JPY
Liabilities and net assets
3,775,634,000 JPY
3,140,313,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.